Loading company
Propanc Biopharma, Inc.
PPCB · Nasdaq · ·
$0.52-8.5%Sep 29 close
- 1M
- -61.4%
- 6M
- -79.6%
- 1Y
- -98.8%
PPCB · Nasdaq · ·
$0.52-8.5%Sep 29 close
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Profit | -$4.6M | -$4.1M | -12.32% |
| Profit per share | -$0.28 | -$12.50 | +97.76% |
| Free Cash Flow | -$1.6M | -$266.2K | -501.73% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Propanc Biopharma, Inc. has no earnings call transcript available.